STAT+: Pharmalittle: More top hospitals aren’t offering Biogen Alzheimer’s drug; Pfizer may lower Covid pill price in poor countries until supplies rise
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
Author: STAT
Opinion: Recognizing obesity as a disease, not a choice, is a step toward health equity
When the American Medical Association recognized obesity as a disease in 2013, doctors and other…
Opinion: Containing Covid-19 requires rapid tests that are highly sensitive to infections. Why is the FDA asking for something different?
With rapid testing becoming a key tool in the fight against Covid-19, in a mid-October…
STAT+: Blueprint Medicines seeks ‘continuity, not change’ in CEO transition
For Jeff Albers, the decision to step down as the CEO of Blueprint Medicines after…
STAT+: ‘It’s almost negligible’: More top hospitals aren’t offering controversial Alzheimer’s drug Aduhelm
WASHINGTON — Almost no one is prescribing Aduhelm, the controversial new Alzheimer’s treatment that roiled…
CDC advisers recommend teens 12 to 17 should receive a Covid-19 booster shot
An expert panel that advises the Centers for Disease Control and Prevention on vaccines voted…
Opinion: The case for Califf: Don’t let politics prevent confirmation of best FDA commissioner candidate
President’s Biden’s nomination of Robert Califf to head the Food and Drug Administration is in…
Study raises doubts about rapid Covid tests’ reliability in early days after infection
A new study raises significant doubts about whether at-home rapid antigen tests can detect the…
Predicting preeclampsia from a blood test holds promise for pregnancy complications
Preeclampsia is a potentially serious problem that usually surfaces late in pregnancy, posing an immediate…
STAT+: Pharmalittle: U.S. doubles order of Pfizer Covid-19 pill; court revives suit claiming drug makers funded terrorism in Iraq
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
Opinion: ‘Protect our hospitals’ might convince Britons to get Covid-19 vaccines, but it won’t work in the U.S.
The resurgence of Covid-19 is again leading health care systems across the globe to brace…
Robert Califf is a fervent believer in data. At the FDA, will that be enough?
At his confirmation hearing last month to lead the Food and Drug Administration, Robert Califf…
STAT+: The health tech tracker for the first quarter: 13 decisive industry events and deals to watch
As we enter the pandemic’s third year, we’ll be watching to see whether skyrocketing digital…
STAT+: 3 CRISPR editing innovations to watch in 2022
During the first year of the Covid-19 pandemic, many of the world’s scientists — including…
STAT+: Chatbots, surveys, and texts: Telehealth companies cut costs by reimagining the front desk
Telehealth companies struggling to stand out in a crowded virtual care market are increasingly leaning…
STAT+: Some drug makers quietly resumed donations to lawmakers who denied Biden’s election victory
Four major drug makers each donated tens of thousands of dollars last year to Republican…
STAT+: Why the conviction of Elizabeth Holmes hinged on defrauding Theranos investors, not patients
The trial of Elizabeth Holmes resulted in a mixed verdict, but one outcome is clear:…
Opinion: Health tech needs to rebuild trust in the wake of the Theranos verdict
Monday’s news that Elizabeth Holmes, the founder and CEO of Theranos, was found guilty of…
STAT+: Applied Therapeutics tried to muzzle short sellers — but the truth still came out
When short sellers began raising questions about New York-based Applied Therapeutics’ treatment for a rare…
Opinion: Opioid overdoses are killing Americans. Improving access to methadone can save lives
The United States recently reached a grim milestone: 100,000 overdose deaths in one year. This…
STAT+: Pharmalittle: Pharma raises median drug prices by 4.9%, so far; Covid forces some lawmakers to ponder pharma gifts
Top of the morning to you, and a fine one it is. Clear skies and…
Holmes convicted of fraud at Theranos & new FDA signposts for digital research tools
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Covid-19 politics force state lawmakers to ponder pharma campaign cash
WASHINGTON — Ohio state Rep. Beth Liston had accepted campaign donations from Pfizer before, but…
Opinion: Confessions of a ‘human guinea pig’: Why I’m resigning from Moderna vaccine trials
In July 2020, I volunteered to be in Moderna’s Covid-19 vaccine trial. If I knew…
STAT+: FDA’s vaccines and biologics chief talks Covid-19, 2022 priorities, and getting back to gene, cell therapy review
WASHINGTON — No part of the Food and Drug Administration has been challenged by the…
‘A black box’: Emergency medics remain locked out of electronic health records
A few years back, Travis Ogden’s ambulance crew raced to revive a 4-year-old who’d drowned,…
STAT+: Texas is trying to create the next research triangle for biotech. Will it work?
Do you live in a city vying to be the country’s next biotech hub? Get…
Jury finds Theranos founder Elizabeth Holmes guilty of fraud
Elizabeth Holmes, the former Theranos CEO who promised to revolutionize medicine but whose company collapsed…
STAT+: Drug makers ring in the new year with 5% price hikes on hundreds of medicines
As 2022 gets under way, pharmaceutical companies have so far raised wholesale prices by a…
STAT+: HHS appeals rulings over drug discount program just as AbbVie is latest to cut discounts
A heated clash over a U.S. government drug discount program has intensified after a federal…
FDA authorizes first Covid-19 booster shot for teens aged 12 to 15
The Food and Drug Administration on Monday extended the emergency use authorization for the Pfizer…
STAT+: Pharmalittle: New Covid-19 vaccine developers expect nothing in return; COVAX distribution falls short of goals
Good morning, everyone, and nice to see you again after a long break. For those…
Opinion: Will the Biden administration use ‘march-in’ to protect prostate cancer patients from excessive drug prices?
Astellas Pharma, a drug company headquartered in Japan, is charging U.S. patients $156,000 a year…
What racism in medicine takes from us
During my freshman year of college, Cornel West, the renowned philosopher, had been invited to…
STAT+: The biotech scorecard for the first quarter: 19 stock-moving events to watch
Happy New Year! Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events,…
A WHO official weighs in on Covid, vaccines, and mistakes that were made
The Covid-19 pandemic has entered its third year, with no end in sight, and the…
Opinion: The No Surprises Act: Beyond the emergency department, a silver lining of patient engagement
When I was pregnant with my first child, I needed a prenatal test that could…
Opinion: My son will be fine, she told the doctors, because he is the Lord God Jesus Christ
Editor’s note: This essay, initially published a year before the emergence of the global coronavirus…
.jpg)
New York jury holds Teva Pharmaceuticals liable in opioid crisis
A jury held Teva Pharmaceuticals responsible Thursday for contributing to the opioid crisis, delivering a…
Beyond case counts: What Omicron is teaching us
The Omicron wave in the United States is upon us. If you were fortunate enough…
Opinion: STAT+: Building a better on-ramp for health innovation
The pandemic crisis has illuminated a stark reality that innovators, particularly those in biotech, have…
We wish we’d written that: STAT staffers share their favorite stories of 2021
All through 2021, journalists around the globe have captivated and inspired our staff at STAT….
Opinion: Deaths of despair: the unrecognized tragedy of working class immiseration
Given the socioeconomic effects of the ongoing Covid-19 pandemic, it should have come as no…
STAT+: Three missing pieces the digital therapeutics sector needs to succeed in 2022
Smartphone apps aren’t a default way of managing diabetes — not yet, anyway. Though telehealth…
3 big questions about the Biden administration’s Covid response in 2022
2021 was supposed to be the year the pandemic ended. At least in the United…
STAT+: 3 biotech trends to watch in 2022
It’s been a weird year for biotech stocks. One major index peaked in February, but…
STAT/Harris Poll: Vaccinated Americans far more likely to take Pfizer Covid-19 pill than unvaccinated people
Just before regulators authorized use of a widely publicized Covid-19 pill from Pfizer, only half…
Opinion: Managing mental health tech’s blitzscaling blind spots
Pro basketball player Giannis Antetokounmpo told GQ magazine last month that he and most of…
STAT+: 3 challenges for hospitals in 2022
WASHINGTON — Hospitals didn’t get the relief the rollout of Covid-19 vaccines seemed to promise at…
STAT’s most memorable photos of 2021
In 2021, STAT’s contributing photographers found themselves on the frontlines on the pandemic once again….